2-ARYLIMIDAZO[1,2-B]PYRIDAZINE, 2-PHENYLIMIDAZO[1,2-A]PYRIDINE, AND 2-PHENYLIMIDAZO[1,2-A]PYRAZINE DERIVATIVES

Disclosed are compounds of formula (I): (Formula (I) where X, Y, X, A, R1; R2, and R3 are defined herein. Also disclosed are pharmaceutically acceptable salts of the compounds, compositions containing the compounds, and methods of using the compounds to treat, e.g., cancer. La présente invention con...

Full description

Saved in:
Bibliographic Details
Main Authors HUANG, KENNETH H, SMITH, EMILIE D, VEAL, JAMES M, OMMEN, ANDY J, ATKINSON, ROBERT N
Format Patent
LanguageEnglish
French
Published 05.03.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds of formula (I): (Formula (I) where X, Y, X, A, R1; R2, and R3 are defined herein. Also disclosed are pharmaceutically acceptable salts of the compounds, compositions containing the compounds, and methods of using the compounds to treat, e.g., cancer. La présente invention concerne des composés de formule (I) : (Formule (I) où X, Y, X, A, R1 ; R2, et R3 sont définis dans la présente description. La présente invention concerne en outre des sels pharmaceutiquement acceptables des composés, des compositions contenant les composés, et des procédés d'utilisation des composés pour traiter, par exemple, le cancer.
Bibliography:Application Number: CA20112821546